Monthly Archives: January 2013
I have macular degeneration: What do I do now?
What Is Macular Degeneration Age-related macular degeneration is a common degenerative condition of the retina that can produce “legal blindness,” usually in retirement age population. About one in 10 individuals in their 50s will display some changes of AMD, and about one in three in their 70s will display AMD changes. There is a definite… Read More
New Macular Degeneration Drug Tested Locally
Patricia Liscinsky of South Fort Myers knew there was something wrong with her vision while driving home from work at a local department store one night. She couldn’t read the street signs, especially at dusk. Her vision became worse day by day until she finally was no longer able to work nights at all. Then… Read More
18th Annual Vision Research Symposia
ThromboGenics Confirms JETREA US Launch Date of Monday January 14th, 2013
Leuven, Belgium – January 4, 2013 – ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, confirms its JETREA® US launch date of Monday January 14th, 2013. JETREA® (ocriplasmin) Intravitreal Injection is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion (VMA). The US price… Read More